Next Article in Journal
Support Vector Data Description Model to Map Specific Land Cover with Optimal Parameters Determined from a Window-Based Validation Set
Next Article in Special Issue
Screening Genotoxicity Chemistry with Microfluidic Electrochemiluminescent Arrays
Previous Article in Journal
Consensus-Based Cooperative Control Based on Pollution Sensing and Traffic Information for Urban Traffic Networks
Previous Article in Special Issue
A Quantitative PCR-Electrochemical Genosensor Test for the Screening of Biotech Crops
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Sensors 2017, 17(5), 961;

Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center of Digestive Diseases, 95 Yong-an Road, Xicheng District, Beijing 100050, China
Beijing Engineering Research Center for BioNanotechnology and CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, Beijing 100190, China
Beijing Entry_Exit Inspection and Quarantine Bureau, 3 Yi, Tianzhu donglu, Tianzhu Airport Industry Area, Shunyi District, Beijing 101312, China
Wuhan Wawasye Nanotech Company, No. 36 Xinjiangongmen Road, Beijing 100191, China
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: María Jesús Lobo-Castañón
Received: 27 February 2017 / Revised: 20 April 2017 / Accepted: 21 April 2017 / Published: 26 April 2017
(This article belongs to the Special Issue Genosensing)
Full-Text   |   PDF [1476 KB, uploaded 26 April 2017]   |  


Quantum dots (QDs) are semiconductor nanoparticles with a diameter of less than 10 nm, which have been widely used as fluorescent probes in biochemical analysis and vivo imaging because of their excellent optical properties. Sensitive and convenient detection of hepatitis B virus (HBV) gene mutations is important in clinical diagnosis. Therefore, we developed a sensitive, low-cost and convenient QDs-mediated fluorescent method for the detection of HBV gene mutations in real serum samples from chronic hepatitis B (CHB) patients who had received lamivudine or telbivudine antiviral therapy. We also evaluated the efficiency of this method for the detection of drug-resistant mutations compared with direct sequencing. In CHB, HBV DNA from the serum samples of patients with poor response or virological breakthrough can be hybridized to probes containing the M204I mutation to visualize fluorescence under fluorescence microscopy, where fluorescence intensity is related to the virus load, in our method. At present, the limits of the method used to detect HBV genetic variations by fluorescence quantum dots is 103 IU/mL. These results show that QDs can be used as fluorescent probes to detect viral HBV DNA polymerase gene variation, and is a simple readout system without complex and expensive instruments, which provides an attractive platform for the detection of HBV M204I mutation. View Full-Text
Keywords: quantum dot; HBV DNA; sequencing; mutation quantum dot; HBV DNA; sequencing; mutation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zhang, C.; Chen, Y.; Liang, X.; Zhang, G.; Ma, H.; Nie, L.; Wang, Y. Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe. Sensors 2017, 17, 961.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top